Search research articles
Contact Us
Filters
Showing results (171-180 of 246) with videos related to
Page
of 25
Sort By:
Neurologic Clinics
|
November 13, 2025
Placebo Response in Acute and Prophylactic Treatment of Migraine: A Systematic Review and Meta-Analysis Covering 36 Years of Research
N R A Bruijn, E M Huessler, A MaassenVanDenBrink, et al.
Neurology
|
April 12, 2006
Syncope in migraine: the population-based CAMERA study
R D Thijs, M C Kruit, M A van Buchem, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1996
Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response
W H Visser, J Burggraaf, L M Muller, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
February 26, 1994
[Multiple value of sumatriptan above that of ergot alkaloids still not proven]
M D Ferrari, J Haan, W Bax, et al.
Neurology
|
October 24, 2001
Comparison of rizatriptan and other triptans on stringent measures of efficacy
J U Adelman, R B Lipton, M D Ferrari, et al.
Brain : a Journal of Neurology
|
May 27, 2008
Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study
G G Schoonman, J van der Grond, C Kortmann, et al.
Clinical Neurology and Neurosurgery
|
November 1, 1995
A four-generation Dutch family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), linked to chromosome 19p13
R Wielaard, M Bornebroek, R A Ophoff, et al.
Cephalalgia : an International Journal of Headache
|
September 15, 2011
Validation of the web-based LUMINA questionnaire for recruiting large cohorts of migraineurs
W P J van Oosterhout, C M Weller, A H Stam, et al.
Cephalalgia : an International Journal of Headache
|
February 11, 2000
Auditory evoked potentials in the assessment of central nervous system effects of antimigraine drugs
K I Roon, P S Sándor, G G Schoonman, et al.
Cephalalgia : an International Journal of Headache
|
November 14, 1997
Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine
H Gijsman, M S Kramer, J Sargent, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 246) with videos related to
Sort By:
Page
of 25
Neurologic Clinics
|
November 13, 2025
Placebo Response in Acute and Prophylactic Treatment of Migraine: A Systematic Review and Meta-Analysis Covering 36 Years of Research
N R A Bruijn, E M Huessler, A MaassenVanDenBrink, et al.
Neurology
|
April 12, 2006
Syncope in migraine: the population-based CAMERA study
R D Thijs, M C Kruit, M A van Buchem, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1996
Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response
W H Visser, J Burggraaf, L M Muller, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
February 26, 1994
[Multiple value of sumatriptan above that of ergot alkaloids still not proven]
M D Ferrari, J Haan, W Bax, et al.
Neurology
|
October 24, 2001
Comparison of rizatriptan and other triptans on stringent measures of efficacy
J U Adelman, R B Lipton, M D Ferrari, et al.
Brain : a Journal of Neurology
|
May 27, 2008
Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study
G G Schoonman, J van der Grond, C Kortmann, et al.
Clinical Neurology and Neurosurgery
|
November 1, 1995
A four-generation Dutch family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), linked to chromosome 19p13
R Wielaard, M Bornebroek, R A Ophoff, et al.
Cephalalgia : an International Journal of Headache
|
September 15, 2011
Validation of the web-based LUMINA questionnaire for recruiting large cohorts of migraineurs
W P J van Oosterhout, C M Weller, A H Stam, et al.
Cephalalgia : an International Journal of Headache
|
February 11, 2000
Auditory evoked potentials in the assessment of central nervous system effects of antimigraine drugs
K I Roon, P S Sándor, G G Schoonman, et al.
Cephalalgia : an International Journal of Headache
|
November 14, 1997
Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine
H Gijsman, M S Kramer, J Sargent, et al.
Page
of 25